Teva holding off launch of opioid addiction drug

As reported by pharmaphorum earlier this week, US regulators quickly approved the therapy to provide another alternative for patients seeking to shake off opioid addiction.

But Reuters reported that Teva has decided not to launch until another court case, where the Israel-based drugmaker is trying to prevent the launch of a generic version produced by India’s Dr Reddy’s Laboratories.